Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

about

Clinical Genetics in Interstitial Lung Disease.

P2860

Q54213046-FD2D58C5-0BEC-4068-A2E4-BDADF71C069B

P2860

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

Item

http://www.wikidata.org/entity/Q41513645

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

@en

type

Item

label

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

@en

prefLabel

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

@en

P1476

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

@en

P2093

Aliya N Husain

http://www.w3.org/2001/XMLSchema#string

Deepa Bhanot

http://www.w3.org/2001/XMLSchema#string

Donald Hedeker

http://www.w3.org/2001/XMLSchema#string

Imre Noth

http://www.w3.org/2001/XMLSchema#string

Jonathan H Chung

http://www.w3.org/2001/XMLSchema#string

Justin M Oldham

http://www.w3.org/2001/XMLSchema#string

Lacey Robinson

http://www.w3.org/2001/XMLSchema#string

Lena Chen

http://www.w3.org/2001/XMLSchema#string

Mark Hamblin

http://www.w3.org/2001/XMLSchema#string

Mary E Strek

http://www.w3.org/2001/XMLSchema#string

P2860

Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue/recovery workers

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis

A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.

Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysis

Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis.

Management of hypersensivity pneumonitis

Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features

P31

scholarly article

P356

10.1183/23120541.00016-2017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ayodeji Adegunsoye

Evans R Fernández Pérez

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28845429

http://www.w3.org/2001/XMLSchema#string

P932

5570511

http://www.w3.org/2001/XMLSchema#string

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

about

P2860

P2860

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932